Literature DB >> 10147232

Treatment perspectives in rheumatoid arthritis: a descriptive study in a Swedish healthcare district.

P Bendtsen1, P Bjurulf, E Trell, F Lindström, J E Larsson.   

Abstract

This study analyses patterns of treatment offered to individuals with a clinical diagnosis of rheumatoid arthritis (RA). A cross-sectional investigation was carried out in 321 patients (aged greater than 16 years) fulfilling the 1958 American Rheumatism Association (ARA) criteria for RA. Medical records were scrutinised retrospectively for information about medical, surgical and other treatments during a 5-year period (1982 to 1986). All patients had received medical treatment, but a large number had discontinued drug therapy because of adverse effects or lack of efficacy. 45.9% of the individuals were receiving 1 drug at the time of the survey, 33.8% were on 2 drugs, 11.7% were on 3 or 4 drugs, and 8.6% were not receiving any medication. Nearly 50% of the patients had had various kinds of surgical procedures performed. The clinical manifestation of the disease, as measured by the number of ARA criteria fulfilled, showed a linear correlation to nearly all medical and surgical treatments. A primary healthcare physician was the basic contact person for 90% of the patients, but in addition 70% of the participants had been examined at sometime by a rheumatological specialist. The study confirms our expectations that patients with RA receive numerous pharmaceutical and other treatments. Even patients with mild and/or early disease (probable RA) had received a considerable amount of treatment. Qualified specialised care was also provided despite the distance to a university referral centre.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 10147232     DOI: 10.2165/00019053-199405050-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  17 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

Review 2.  50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis.

Authors:  F Wolfe
Journal:  J Rheumatol Suppl       Date:  1990-05

3.  Conflict between epidemiological and clinical diagnosis of rheumatoid arthritis in a population sample.

Authors:  E Allander
Journal:  Scand J Rheumatol       Date:  1973       Impact factor: 3.641

Review 4.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

Review 5.  The epidemiology of rheumatoid arthritis.

Authors:  J T Gran
Journal:  Monogr Allergy       Date:  1987

Review 6.  Pathogenesis of rheumatoid arthritis.

Authors:  E D Harris
Journal:  Clin Orthop Relat Res       Date:  1984 Jan-Feb       Impact factor: 4.176

7.  Increased mortality in rheumatoid arthritis.

Authors:  P Allebeck
Journal:  Scand J Rheumatol       Date:  1982       Impact factor: 3.641

8.  Prognostic factors and diagnostic criteria in early rheumatoid arthritis.

Authors:  K Kaarela
Journal:  Scand J Rheumatol Suppl       Date:  1985

9.  Perceived needs and patient satisfaction in relation to care provided in individuals with rheumatoid arthritis.

Authors:  P Bendtsen; P Bjurulf
Journal:  Qual Assur Health Care       Date:  1993-09

10.  Rheumatic diseases in a health interview survey and in in-patient care. A record linkage study on two registers.

Authors:  P Allebeck; G Lindberg
Journal:  Scand J Soc Med       Date:  1984
View more
  2 in total

Review 1.  A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.

Authors:  Hendra Goh; Yu Heng Kwan; Yi Seah; Lian Leng Low; Warren Fong; Julian Thumboo
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

Review 2.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.